US Stock MarketDetailed Quotes
VIGL Vigil Neuroscience
- 3.870
- 0.0000.00%
Close Nov 4 16:00 ET
- 3.870
- 0.0000.00%
Post 16:02 ET
153.44MMarket Cap-1834P/E (TTM)
4.000High3.828Low28.91KVolume3.840Open3.870Pre Close112.90KTurnover0.14%Turnover RatioLossP/E (Static)39.65MShares6.98052wk High1.80P/B81.13MFloat Cap2.47052wk Low--Dividend TTM20.96MShs Float18.270Historical High--Div YieldTTM4.44%Amplitude2.180Historical Low3.904Avg Price1Lot Size
Vigil Neuroscience Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -0.97%-15.5M | 1.37%-21.88M | -8.00%-70.36M | 9.23%-15.51M | -8.72%-17.31M | -9.72%-15.35M | -22.28%-22.19M | -65.58%-65.15M | 1.50%-17.09M | -43.82%-15.93M |
| Net income from continuing operations | -5.22%-21.23M | -0.73%-19.94M | -20.98%-82.64M | -20.15%-22.17M | -17.11%-20.5M | -18.57%-20.17M | -29.09%-19.8M | -57.81%-68.31M | -42.13%-18.46M | -62.94%-17.5M |
| Operating gains losses | ---- | ---- | ---8K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 1.80%113K | 73.85%113K | 411.54%399K | 438.10%113K | 423.81%110K | 516.67%111K | 261.11%65K | 178.57%78K | 40.00%21K | 75.00%21K |
| Other non cash items | -3.58%350K | 8.49%345K | 46.35%1.36M | 34.78%341K | 47.41%342K | 59.21%363K | 45.21%318K | -21.08%932K | 48.82%253K | 41.46%232K |
| Change In working capital | 8.26%3.08M | -0.49%-4.29M | 193.01%3.1M | 947.54%3.44M | 725.00%1.08M | 116.43%2.85M | -4.82%-4.26M | -618.85%-3.33M | 92.35%-406K | 83.85%-172K |
| -Change in prepaid assets | -36.05%1.36M | -297.88%-932K | 213.67%4.18M | 190.10%2.24M | 32.57%-648K | 182.18%2.12M | 147.72%471K | 25.17%-3.68M | 48.39%-2.48M | -24.64%-961K |
| -Change in payables and accrued expense | 80.52%1.94M | 36.25%-3.09M | -124.98%-379K | -37.87%1.49M | -3.93%1.91M | 6,806.25%1.07M | -70.25%-4.85M | -74.49%1.52M | 943.31%2.4M | 1,372.44%1.99M |
| -Change in other current assets | --11K | ---43K | 67.95%-83K | 1.19%-83K | --0 | --0 | --0 | -338.98%-259K | -95.35%-84K | -4,690.48%-964K |
| -Change in other current liabilities | 35.82%-224K | -296.43%-220K | 31.46%-623K | 13.30%-202K | 20.69%-184K | -54.42%-349K | 151.38%112K | -177.13%-909K | -37.87%-233K | -45.91%-232K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -0.97%-15.5M | 1.37%-21.88M | -8.00%-70.36M | 9.23%-15.51M | -8.72%-17.31M | -9.72%-15.35M | -22.28%-22.19M | -65.58%-65.15M | 1.50%-17.09M | -43.82%-15.93M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 104.72%1.04M | 123.86%16.47M | -6,972.53%-65.14M | 4,017.28%10.66M | 3,781.25%15.31M | -24,189.01%-22.1M | -48,494.37%-69M | -351.47%-921K | -907.41%-272K | -288.79%-416K |
| Net PPE purchase and sale | 95.90%-5K | --0 | 26.82%-674K | 95.22%-13K | 88.70%-47K | -34.07%-122K | -246.48%-492K | -351.47%-921K | -907.41%-272K | -288.79%-416K |
| Net investment purchase and sale | 104.77%1.05M | 124.03%16.47M | ---64.46M | --10.67M | --15.36M | ---21.98M | ---68.51M | --0 | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 104.72%1.04M | 123.86%16.47M | -6,972.53%-65.14M | 4,017.28%10.66M | 3,781.25%15.31M | -24,189.01%-22.1M | -48,494.37%-69M | -351.47%-921K | -907.41%-272K | -288.79%-416K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -98.45%9K | 2,453.69%5.18M | -99.45%888K | -47.52%53K | -99.93%53K | 276.52%579K | -99.77%203K | 49.66%161.26M | 105.42%101K | -20.53%71.29M |
| Net issuance payments of debt | --0 | --0 | 46.51%-23K | --0 | 81.82%-2K | 9.09%-10K | -10.00%-11K | -13.16%-43K | -10.00%-11K | -37.50%-11K |
| Net common stock issuance | --0 | --5.18M | --0 | --0 | --0 | --0 | --0 | --140.47M | ---8K | --50.6M |
| Proceeds from stock option exercised by employees | -98.47%9K | --0 | -95.63%911K | -55.83%53K | -99.73%55K | 29,350.00%589K | 2,277.78%214K | 54,721.05%20.83M | 215.79%120K | --20.7M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -98.45%9K | 2,453.69%5.18M | -99.45%888K | -47.52%53K | -99.93%53K | 276.52%579K | -99.77%203K | 49.66%161.26M | 105.42%101K | -20.53%71.29M |
| Net cash flow | ||||||||||
| Beginning cash position | -45.43%52.69M | -71.78%52.92M | 103.07%187.53M | -71.81%57.72M | -60.18%59.67M | -41.22%96.55M | 103.07%187.53M | 282.37%92.35M | 83.53%204.79M | 353.25%149.84M |
| Current changes in cash | 60.82%-14.45M | 99.75%-231K | -241.42%-134.61M | 72.18%-4.8M | -103.54%-1.95M | -155.88%-36.88M | -226.54%-90.99M | 39.58%95.19M | 10.28%-17.26M | -30.02%54.95M |
| End cash Position | -35.91%38.24M | -45.43%52.69M | -71.78%52.92M | -71.78%52.92M | -71.81%57.72M | -60.18%59.67M | -41.22%96.55M | 103.07%187.53M | 103.07%187.53M | 83.53%204.79M |
| Free cash flow | -0.21%-15.51M | 3.51%-21.88M | -7.52%-71.04M | 10.58%-15.52M | -6.24%-17.36M | -9.88%-15.48M | -24.02%-22.68M | -67.05%-66.07M | 0.09%-17.36M | -46.16%-16.34M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data